期刊文献+

VEGF和突变型p53在胃癌组织表达及意义 被引量:19

VEGF and mutant p53 expression in gastric carcinoma and significance
下载PDF
导出
摘要 目的:通过检测胃癌及癌前病变患者活检组织中血管内皮生长因子(VEGF)和突变型p53基因(mtp53)的表达,探讨VEGF和突变型p53基因在胃癌发生发展中的临床意义。方法:通过胃镜组织活检收集19例正常胃组织、22例肠上皮化生、47例胃肠黏膜不典型增生、54例胃癌样本,通过免疫组织化学染色检测组织中VEGF和mtp53的表达水平。结果:VEGF、mtp53的表达水平在正常胃组织,肠上皮化生,不典型增生以及胃癌中呈逐渐增高的规律。胃癌组织中VEGF和mtp53表达较正常胃组织、肠上皮化生组织显著增高(P<0.05),而与不典型增生组织差异无统计学意义(P>0.05)。结论:VEGF与突变型p53的异常表达可能与胃组织病变的恶化程度有关。 Objective: To detect precancerous lesions of gastric cancer and biopsy tissue vascular endothelial growth factor (VEGF) and mutant p53 gene(mtp53) expression, to explore the development of clinical significance of VEGF' and mutant p53 gene in gastric cancer. Methods: 19 Cases by endoscopic biopsies of normal gastric tissues ,22 cases of intestinal metaplasia,47 cases of gastro- intestinal mucosal dysplasia, 54 cases of gastric cancer samples by immunohistochemical staining to detect the expression levels of VEGF and mtp53's. Results: The expression levels of VEGF, mtp53 in normal gastric mucosa, intestinal metaplasia, dysplasia, and gradually increased gastric cancer was the law. mtp53 of VEGF expression in gastric carcinoma and compared with normal gastric tissue, intestinal metaplasia was significantly higher( P〈0. 05 ), but with atypical hyperplasia was no significant difference (P〉 0. 05 ). Conclusion: The abnormal expression of VEGF and mutant p53 may be related to the degree of deterioration of the stomach tissue lesions related.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2016年第1期90-91,96,共3页 Chinese Journal of Immunology
基金 胃癌组织中VEGF及突变型p53基因表达及临床意义研究(No.2012GNS042-1)项目
关键词 VEGF 突变型P53 胃癌 癌前病变 VEGF Mutant p53 Gastric cancer Precancerous lesions
  • 相关文献

参考文献11

  • 1Gao L, Cheng W, Zhu XG, et al. VEGF somatostatin in gastric cancer SGC-7901 cells, the influence of the NF-kappa B expression[ J ]. J Suzhou Univ ( Medical Edition ) , 2010, ( 3 ) : 483-486.
  • 2Liu J, Zhang C, Hu WW, et al. Tumor suppressor p53 and its mutants in cancer metabolism [ J ]. Cancer Letters, 2015, (356) : 197 -203.
  • 3Samudio IJ, Duwuri S, Dwyer Clise-K, et al. Activation p53signaling by MI-63 induces apoptosis in acute myeloid leukemia cells[ J]. Leuk diagnosed with lymphoma,2010,51 (5) : 911-919.
  • 4荣晓云,王言奎.宫颈癌及癌前病变组织FoxM1和VEGF表达及相关性[J].齐鲁医学杂志,2011,26(6):471-473. 被引量:8
  • 5Kathleen Saavedra, José Valbuena, Wilda Olivaresl, et al. Loss of expression of reprimo, a p53-induced cell cycle arrest gene, correlates with invasive stage of tumor progression and p73 expression in gastric cancer[J] Plos One,2015, Doi. 10. 1371/ journal, pone. 0125834.
  • 6俞继卫,姜波健,倪晓春,吴巨钢,李小强.联合评估survivin和p53在胃癌组织中表达的临床意义及对预后的影响[J].国际外科学杂志,2007,34(3):156-160. 被引量:6
  • 7王晓龙,张成武,刘宁,马晓明,缪巍,孙伟.P53基因Arg72Pro单核苷酸多态性与青海地区人群胃癌易感性的相关性分析[J].中国免疫学杂志,2014,30(2):178-181. 被引量:5
  • 8Bilgi CI, Tez M. Serum VEGF levels in gastric cancer patients: correlation with clinicopathological parameters [ J ]. Turk J Med Sci,2015,45 (1) :112-117.
  • 9Chavez-Perez VA, Strasberg-Rieber M, Rieber M. Metabolic utilization of xogenous pyruvate by mutant p53 (R175H)human melanoma cells promotes survival under glucose depletion [ J ]. Cancer Biol Therapy,2011,12(7) : 647-656.
  • 10Wei Zhe-Wei, Xia Guang-Kai, Wu Ying, et al. a CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer[ J ] Cancer Letters, 2015, (359) :335-343.

二级参考文献31

  • 1南今娘,陈春杰,胡续光,金昱.p53 codon72多态性与延边地区乳腺癌发生的相关性[J].延边大学医学学报,2010,33(4):243-246. 被引量:3
  • 2Hao Deng,Ren-Liang Wu,Hong-Yan Zhou,Xuan Huang,Ying Chen,Li-Jiang Liu.Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer[J].World Journal of Gastroenterology,2006,12(7):1013-1017. 被引量:27
  • 3张建海,李继坤.新型抑癌基因Runx3与胃癌的研究进展[J].国际外科学杂志,2006,33(6):421-425. 被引量:3
  • 4WEIGEL D. The homeotic gene fork head encodes a nuclear protein and is expressed in the real regions of the Drosophila embryo[J]. Cell, 1989,57:645-658.
  • 5REMMELE W, STEGNER H E. Recommendation for uni form definition of an immunoreaetive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue[J]. Pathologe, 1987(3) :138-140.
  • 6JAMILA L, MARIE S, REN H. FoxM1 : at the crossroads of ageing and cancer[J]. Biochimicaet Biophysica Acta, 2007, 1775:92-102.
  • 7GUAN P, CHEN H, LI H J, et al. Expression and signifi cance of FoxM1 in human cervical cancer: a tissue micro-array study[J]. Clin Invest Med, 2011,34(1) :E1-7.
  • 8GUIDI A J, ABU-JAWDEH G, BERSE B, et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia [J]. J Natl Cancer Inst, 1995,87(16) :1237-1245.
  • 9LONCASTER J A, COOPER R A, LOGUE J P, et al. Vascular endothelial growth factor (VEGF)expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of thecervix[J]. BrJ Cancer, 2007,83(5) :620-625.
  • 10LI Q, ZHANG N, J1A Z L, et al. Critical role and regulation of transcription factor FoxM1 in human gastrie cancer angiogenesis and progression[J]. Cancer Res, 2009,69 : 3501-3509.

共引文献16

同被引文献210

引证文献19

二级引证文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部